For research use only. Not for therapeutic Use.
Imiquimod is a prescription medication that acts as an immune response modifier. Imiquimod signals to the innate arm of the immune system through the toll-like receptor 7 (TLR7), commonly involved in pathogen recognition. Cells activated by imiquimod via TLR-7 secrete cytokines (primarily interferon-α (INF-α), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)). Imiquimod, when applied to skin, can lead to the activation of Langerhans cells, which subsequently migrate to local lymph nodes to activate the adaptive immune system. Other cell types activated by imiquimod include natural killer cells, macrophages and B-lymphocytes.
| Catalog Number | A001023 |
| CAS Number | 99011-02-6 |
| Synonyms | 99011-02-6; Aldara; Zyclara; 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine; Beselna |
| Molecular Formula | C14H16N4 |
| Purity | ≥95% |
| Storage | -20°C |
| InChI | 1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17) |
| InChIKey | DOUYETYNHWVLEO-UHFFFAOYSA-N |
| SMILES | CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N |
| Reference | 1: Kawaguchi M, Oka T, Sugaya M, Suga H, Kimura T, Morimura S, Fujita H, Sato S. 2: Ogawa H, Luxardi G, Kirane A, Kulkarni R, Monjazeb AM, Cheng MY, Ma C, 3: Neugebauer R, Levandoski KA, Zhu Z, Sokil M, Chren MM, Friedman GD, Asgari MM. 4: Wang P, Zhang L, Zhang G, Zhou Z, Zhang H, Zhao Z, Wang LSX. Successful 5: Tio D, Kirtschig G, Hoekzema R, van Montfrans C. Lymphoedema in Lentigo 6: Yu A, Tanizaki H, Kokunai Y, Kaneda K, Sugimoto A, Otsuka T, Kurokawa T, 7: Shaw KS, Nguyen GH, Lacouture M, Deng L. Combination of imiquimod with 8: Higashi Y, Yamakuchi M, Fukushige T, Ibusuki A, Hashiguchi T, Kanekura T. 9: Serra-Guillén C, Nagore E, Llombart B, Sanmartín O, Requena C, Calomarde L, 10: Kim HJ, Kim SH, Kim TG, Park JY, Lee M, Kim DS, Lee MG. Interleukin-21 |
